DE69722610D1 - Neue Inhalationspräparate enthaltend CR 2039 (Andolast) - Google Patents

Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Info

Publication number
DE69722610D1
DE69722610D1 DE69722610T DE69722610T DE69722610D1 DE 69722610 D1 DE69722610 D1 DE 69722610D1 DE 69722610 T DE69722610 T DE 69722610T DE 69722610 T DE69722610 T DE 69722610T DE 69722610 D1 DE69722610 D1 DE 69722610D1
Authority
DE
Germany
Prior art keywords
andolast
preparations containing
pharmaceutically
inhalation preparations
new inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69722610T
Other languages
English (en)
Other versions
DE69722610T2 (de
Inventor
Francesco Makovec
Paolo Senin
Lucio Claudio Rovati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of DE69722610D1 publication Critical patent/DE69722610D1/de
Application granted granted Critical
Publication of DE69722610T2 publication Critical patent/DE69722610T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69722610T 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast) Expired - Lifetime DE69722610T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97830417A EP0896821B1 (de) 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Publications (2)

Publication Number Publication Date
DE69722610D1 true DE69722610D1 (de) 2003-07-10
DE69722610T2 DE69722610T2 (de) 2004-04-29

Family

ID=8230753

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722610T Expired - Lifetime DE69722610T2 (de) 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Country Status (9)

Country Link
US (1) US5976576A (de)
EP (1) EP0896821B1 (de)
JP (1) JP4301598B2 (de)
AT (1) ATE241980T1 (de)
AU (1) AU735204B2 (de)
CA (1) CA2244357C (de)
DE (1) DE69722610T2 (de)
ES (1) ES2199336T3 (de)
PT (1) PT896821E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
US7037927B2 (en) * 2003-10-16 2006-05-02 Abbott Laboratories Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
WO2005123072A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods and compositions for the treatment of pulmonary diseases
WO2005123071A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers
PT1634595E (pt) * 2004-08-19 2008-08-28 Rottapharm Spa Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc)
WO2007077164A1 (en) * 2006-01-06 2007-07-12 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and andolast
DE602006007211D1 (de) * 2006-04-10 2009-07-23 Rottapharm Spa Neue kristalline und stabile Form von Andolast
PT2054057E (pt) * 2006-07-31 2011-05-05 Rottapharm Spa Combina??o de andolast/glucocortic?ides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
CA2126685C (en) * 1992-10-26 2002-07-23 Bruno Gander Process for the production of microcapsules
US5453368A (en) * 1993-08-27 1995-09-26 Brown University Research Foundation Method of encapsulating biological substances in microspheres
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5741168A (en) * 1996-06-21 1998-04-21 Chen; Ming-Sheng Toy glider as folded and assembled from two-dimensional elements

Also Published As

Publication number Publication date
ATE241980T1 (de) 2003-06-15
US5976576A (en) 1999-11-02
EP0896821B1 (de) 2003-06-04
DE69722610T2 (de) 2004-04-29
JP4301598B2 (ja) 2009-07-22
ES2199336T3 (es) 2004-02-16
EP0896821A1 (de) 1999-02-17
CA2244357A1 (en) 1999-02-08
AU735204B2 (en) 2001-07-05
PT896821E (pt) 2003-08-29
JPH11106339A (ja) 1999-04-20
CA2244357C (en) 2007-05-01
AU7732798A (en) 1999-02-18

Similar Documents

Publication Publication Date Title
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
DE69523438T2 (de) Orale metoprolol-dosisform des typs "einmal täglich"
EP1468679A3 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
CY1107966T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν μετφορμινη και γλιβενκλαμιδη για τη θεραπεια του σακχαρωδους διαβητη τυπου ii
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
FI950947A0 (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
DK581889A (da) Antiatherosclerotiske diarylforbindelser
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
EP0667163A4 (de) Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
DK0521393T3 (da) Dichlofenac-cholinsalt, fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder det
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
EP0759297A4 (de) Medikament gegen pulmonale herzprobleme
MX9304403A (es) Derivados farmacologicamente activos de ó-(aminometilo terciario)-bencenmetanol
SE9101687L (sv) Dikloranilinfoerening
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROTTAPHARM S.P.A., MILANO, IT